David Stuart is a director with RSM US LLP’s management consulting practice, responsible for supporting local and cross-border transactions, managing and leading mergers and acquisitions, and supporting strategy advisory services in the private and public company sectors. 

In May 2020, David was selected as a senior analyst in RSM’s cutting-edge Industry Eminence Program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves. In his senior analyst role, David’s focus is on the life sciences industry. He is based in the firm’s San Francisco office. 

David has more than 10 years of experience within the capital markets industry, with extensive experience in mergers and acquisitions, financial advisory, and helping clients assess and solve complex strategic issues. He directly manages a pool of experienced managers and analysts and leverages RSM’s full financial services offerings when required. 

As a member of the Industry Eminence Program, David collaborates across all lines of business to grow the life sciences industry practice. He is focused on supporting RSM’s medical technology subsector within life sciences. He provides clients with thoughtful insights supported by industry data to help determine and analyze emerging sector trends and issues. Beyond life sciences, David also has deep experience in the technology, telecommunications, alternative energy and consumer products sectors.

Prior to joining RSM, David worked at a large financial institution focused on transactions across the capital structure. He started his career at GE Capital and served a leading middle market Canadian private equity firm. Born and raised in Canada, David recently transferred to RSM’s San Francisco office.

• Association for Corporate Growth, board member 

• Passed CFA Level II exam (June 2019)

• Bachelor of Commerce, finance, University of Calgary